Cointime

Cicero Diagnostics

company

About

Cicero Diagnostics is a women’s healthcare diagnostic company.

  • 1 - 10

Highlights

Total Funding Amount
$1M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1M
Industries
Health Care,Health Diagnostics,Women's
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Cicero Diagnostics is a women’s healthcare diagnostic company. It is dedicated to the advancement of clinical assays for understudied women’s diseases primarily in the area of infertility. Its current testing platforms, under the brand ReceptivaDx™ , include several biomarkers highly associated with inflammation on the uterine lining most often diagnosed as endometriosis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1M
Cicero Diagnostics has raised a total of $1M in funding over 2 rounds. Their latest funding was raised on Feb 19, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 19, 2020 Grant $1M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cicero Diagnostics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
เนื้อหา
บริษัท